Ipratropium bromide and Enulose drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ipratropium bromide (ipratropium bromide) and Enulose (lactulose). Common drug interactions include bundle branch block left among females and acute myocardial infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Ipratropium bromide and Enulose. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.

What is Enulose?

Enulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 711 Enulose users. Check the latest studies of Enulose.



On Jul, 13, 2026

13 people who take Ipratropium bromide and Enulose together, and have interactions are studied.

Ipratropium bromide and Enulose drug interactions.

What are the common drug interactions of Ipratropium Bromide and Enulose, by gender? *:

female:

  1. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  2. Burning sensation
  3. Butterfly rash
  4. C-reactive protein increased
  5. Cardiac failure congestive
  6. Cardiac flutter (abnormal heart rhythm)
  7. Cardiac hypertrophy (thickening of the heart muscle)
  8. Cardioactive drug level above therapeutic
  9. Cardioactive drug level below therapeutic
  10. Cardiolipin antibody positive

male:

  1. Acute myocardial infarction (acute heart attack)
  2. Aortic valve incompetence
  3. Brain contusion (a form of traumatic brain injury)
  4. Cardiac arrest
  5. Cardiac failure congestive
  6. Cardioactive drug level below therapeutic
  7. Cardiogenic shock (inadequate circulation of blood)
  8. Cardiomegaly (increased size of heart than normal)
  9. Cardiomyopathy (weakening of the heart muscle)
  10. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)

What are the common drug interactions of Ipratropium Bromide and Enulose, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Blood chloride decreased
  2. Blood glucose decreased
  3. Blood glucose increased
  4. Blood immunoglobulin g increased
  5. Blood sodium decreased
  6. Blood thyroid stimulating hormone decreased
  7. Blood thyroid stimulating hormone increased
  8. Body temperature increased
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. C-reactive protein increased

60+:

  1. Abdominal pain
  2. Fall
  3. Catheter site swelling
  4. Fatigue (feeling of tiredness)
  5. Fungal skin infection
  6. Small intestinal obstruction (blockage in small intestine)
  7. Upper respiratory tract infection
  8. Laryngeal discomfort
  9. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  10. Chronic kidney disease

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
  2. Neuralgia (pain in one or more nerves): 2 people, 15.38%
  3. Kidney Stones: 2 people, 15.38%
  4. High Blood Pressure: 2 people, 15.38%
  5. High Blood Cholesterol: 2 people, 15.38%
  6. Gout (uric acid crystals building up in the body): 2 people, 15.38%
  7. Gastric Ulcer (stomach ulcer): 2 people, 15.38%
  8. Diabetes: 2 people, 15.38%
  9. Cardiac Disorder: 2 people, 15.38%
  10. Back Pain: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Ipratropium bromide and Enulose?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ipratropium bromide and Enulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Enulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ipratropium bromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Enulose and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide and lactulose (the active ingredients of Ipratropium bromide and Enulose, respectively), and Ipratropium bromide and Enulose (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: